“…SEER data are used widely as a bench-mark data source for studying MB/PNET cancer outcomes in US and in other countries (Barnholtz-Sloan et al, 2005;Bishop et al, 2012;Curran et al, 2009;Deorah et al, 2006;Gatta et al, 2002;Halperin et al, 2004;Lai, 2008;Smoll, 2012). The extensive ground coverage by the SEER data is ideal for identifying the disparity in oncology outcome and treatment in different geographical and cultural areas (Cheung, 2013a(Cheung, , 2013b(Cheung, , 2013cCheung, 2012;Cheung, 2013;Downing et al, 2010;Gross et al, 2008;Harlan et al, 1995;Lund et al, 2008;Martinez et al, 2010;Martinez Min Rex Cheung Schlichting et al, 2012;Shavers et al, 2003;Wampler et al, 2005;Yao et al, 2012). In addition to the biological staging factors and the treatment factors, this database also contains a large number of county level socio-economic factors data.…”